杀死代谢休眠细胞的新策略直接绕过了活跃细胞过程的需要
Karolina Stojowska-Swędrzyńska1, Dorota Kuczyńska-Wiśnik1, Ewa Laskowska1
1Department of General and Medical Biochemistry, Faculty of Biology, University of Gdansk, Wita Stwosza 59, 80-308 Gdansk, Poland.
Antibiotics (Basel, Switzerland)
|June 28, 2023
概括
持久性细胞导致抗生素治疗失败. 针对细菌细胞包裹和生物膜与抗生素一起使用新型药物,提供了一种有希望的策略来对抗这些休眠细胞和反复感染.
科学领域:
- 微生物学 微生物学
- 传染性疾病 传染性疾病
- 药物发现 药物发现 药物发现
背景情况:
- 持久性细胞是休眠的细菌,导致抗生素治疗失败和复发性感染.
- 这些细胞可以促进抗菌素耐药性和耐药突变的选择.
- 耐多药性感染需要针对休眠细菌群的新策略.
研究的目的:
- 审查有效对抗持久细胞的抗微生物药物.
- 讨论针对细菌细胞外结构的策略,独立于代谢状态.
- 探索抗生物膜方法来对抗持久性感染.
主要方法:
- 对向细胞外结构的药物 (例如细胞壁水解酶,多糖脱聚合酶,抗菌) 的文献综述.
- 讨论抑制或降解生物膜矩阵的策略.
- 分析将新药与标准抗生素结合的潜力.
主要成果:
- 向细胞外结构的药物对持久细胞表现出有效性.
- 生物膜形成的抑制剂或矩阵降解剂对于抗持久性策略至关重要.
- 与标准抗生素的结合方法提高了疗效.
结论:
- 针对细菌细胞外和生物膜的新型抗菌剂对于对抗持久细胞至关重要.
- 将这些药物与常规抗生素结合起来,是一个有前途的治疗策略.
- 针对持久性细胞对于管理多抗药性感染至关重要.
相关概念视频
Overview of Cell Death
7.4K
Cell death is an essential process where the body gets rid of old or damaged cells. Cell proliferation and death need to be balanced, as an imbalance between the two may lead to cancer or autoimmune diseases.
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the...
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the...
7.4K
Adaptive Mechanisms in Cancer Cells
5.8K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.8K
Treatment Resistant Cancers
3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K
Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
Mechanisms of Drug Absorption: Paracellular, Transcellular, and Vesicular Transport
603
Drugs need to permeate cell membranes to reach their target sites after administration. Orally administered drugs must transcend intestinal epithelial membrane barriers to infiltrate the systemic circulation. Drugs with a molecular weight of less than 500 Daltons diffuse through gaps between neighboring cells, called paracellular pathways.
However, most drugs use the transcellular route, traversing directly through the cell membranes via two mechanisms: passive and active transport. Passive...
However, most drugs use the transcellular route, traversing directly through the cell membranes via two mechanisms: passive and active transport. Passive...
603
Autophagic Cell Death
3.5K
Christian de Duve discovered “autophagy,” a process in which cellular components are engulfed by membrane-bound organelles called autophagosomes. The autophagosomes then fuse with lysosomes to digest the enclosed contents. Autophagy is generally activated in cells to prevent cell death. However, cell death is triggered when the damage is beyond repair.
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
3.5K


